Article Versions Notes

Alcaraz A, Castro-Díaz D, Gacci M, Salonia A, Ficarra V, Carballido-Rodríguez J, Rodríguez-Antolín A, Medina-Polo J, Fernández-Gómez JM, Cózar-Olmo JM, et al. Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study. Journal of Clinical Medicine. 2022; 11(13):3615. https://doi.org/10.3390/jcm11133615

Alcaraz, Antonio, David Castro-Díaz, Mauro Gacci, Andrea Salonia, Vincenzo Ficarra, Joaquín Carballido-Rodríguez, Alfredo Rodríguez-Antolín, José Medina-Polo, Jesús M. Fernández-Gómez, José M. Cózar-Olmo, and et al. 2022. "Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study" Journal of Clinical Medicine 11, no. 13: 3615. https://doi.org/10.3390/jcm11133615

Alcaraz, A., Castro-Díaz, D., Gacci, M., Salonia, A., Ficarra, V., Carballido-Rodríguez, J., Rodríguez-Antolín, A., Medina-Polo, J., Fernández-Gómez, J. M., Cózar-Olmo, J. M., Búcar-Terrades, S., Pérez-León, N., Brenes-Bermúdez, F. J., Molero-García, J. M., Fernández-Pro-Ledesma, A., Herdman, M., Angulo, J. C., Manasanch, J., & on behalf of the QUALIPROST Study Group. (2022). Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study. Journal of Clinical Medicine, 11(13), 3615. https://doi.org/10.3390/jcm11133615